Melissa Quinn previously worked for The Daily Signal as a senior news reporter. Seeking a more robust defense in the event of a bioterrorist attack on the United States, the Bush administration ...

Acambis'smallpox vaccine will be among the first biodefense products to come to market under the three-month old US BioShield law. Three years after the terrorists attacks and anthrax scare in the ...

Congress approved legislation that would guarantee a government market for medical countermeasures against a biological, chemical, radiological or nuclear attack. The chamber voted 414-2 in favor of a ...

Less than a year after legislation to spur the development of new bioterror countermeasures became law, a policy debate is playing out in the Senate over what ...